MIAMI, FLORIDA, May 9, 2022 – Ei.Ventures Inc. ("Ei" or the "Company"), a technology company empowering mental wellness through psychoactive compounds, nutraceuticals and web 3.0 is pleased to announce its progress since the completion of its Regulation A+ financing round on March 22.
David Nikzad, founder and CEO of Ei explains: "It has always been – and remains to be – our mission to impact one billion people through natural therapies and remedies. I believe our recent corporate actions and investments speak volumes that we are on target – and the momentum is accelerating."
Update on recent Achievements:
Strategic Investment: Avicanna Inc.
On the recent $1.111 million investment in Toronto-based Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), Nikzad continues: "We are excited to make this strategic investment in Avicanna. We believe in the Avicanna team and their mission to develop advanced and proprietary plant-based formulations, and we intend scale our investment and bring our blockchain, Web 3.0 and Metaverse assets to support the continued success of Avicanna and its products."
Avicanna is a commercial stage, international biopharmaceutical company with existing and planned licenses in cannabis, CBD, and psychedelics. With a pharmaaceutical pipeline with over 50 formulations in development, Avicanna will be a strategic partner in Ei's development of its proprietary, plant-based formulations.
Strategic Investment: Odyssey Elixir
Ei has also made a recent investment in privately held Odyssey Elixir. The $1.111 million commitment is to help the Fort Lauderdale-based Odyssey scale its line of groundbreaking functional mushroom beverages, which have been well received in multiple markets across the U.S. With Ei Ventures support and capital and community, Odyssey will be a continued strategic partner in Ei's development of functional mushroom products.
Further, the Ei team is strategizing with both Avicanna and Odyssey to launch a retail store in the metaverse that contains all the products from both companies, respectively.
Update on LOI with Mycotopia:
As previously reported, Ei Ventures continues to move forward with its merger plans with publicly traded Mycotopia (OTC: TPIA). The Miami-based company provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.
Founder Jason Hobson explains: "With these recent corporate actions, we continue on our way to provide the healing benefits, therapies, and treatments both online and offline at a time when they are needed more than ever. We will continue to develop our presence in Web3 and Blockchain in order to achieve transparency and in keeping with our vision for 100% plant based and non-synthetic products. We are well on our way."
On Behalf of the Board,
David Nikzad
Founder and CEO
About Ei.Ventures
Ei.Ventures Inc. in an early stage tech company empowering mental wellness through psychoactive compounds, nutraceuticals and technology. Ei.Ventures is leveraging blockchain, emerging technologies and the Metaverse to deliver governmental approved therapeutic treatment options that address the current global mental healthcare pandemic. It is goal of the company to utilize the development of these technologies, to create a safe, efficient, and secure way to provide telehealth services in general and specifically to the psychoactive therapeutics. https://www.ei.ventures
About Avicanna Inc.
Avicanna is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, medical and pharmaceutical market segments. In leading global cannabinoid advancements, The Company actively collaborates with leading Canadian academic and medical institutions in research and commercialization. Avicanna has established an industry-leading scientific platform including advanced R&D and clinical development that has led to the commercialization of more than thirty products across its main market segments:
Medical Cannabis & Wellness Products: Marketed under the RHO Phyto™ brand these medical and wellness products are an advanced line of pharmaceutical-grade cannabinoid products containing varying ratios of cannabidiol ("CBD") and tetrahydrocannabinol ("THC"). The product portfolio contains a full formulary of products including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data. The advanced formulary is marketed with consumer, patient and medical-community education and training.
Pharmaceutical Pipeline: Leveraging Avicanna's scientific platform, vertical integration, and real-world evidence, Avicanna has created a pipeline of patent-pending drug candidates that are indication-specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders. Avicanna's first pharmaceutical preparation (Trunerox™) is in the drug registration stage in South America.
About Odyssey Elixir
Based in Fort Lauderdale, Florida, Odyssey Elixir is an emerging, fast-growing RTD functional beverage company. Their innovative and exotic flavor-forward, functional mushroom elixirs are rich in active compounds found in the fruiting body of a mushrooms such as Shitake, Lion's Mane, Reishi, Turkey Tail, Maitake, Chaga, and Cordyceps. These mushrooms have been revered throughout history as having medicinal qualities.
About MycotopiaTherapies
Mycotopia Therapies (OTC:TPIA) focuses on helping you heal and reclaim your life. Your journey of healing is an understanding of the causes and works to mental wellness through psychedelic enhanced psychotherapy, integrated with a professional team of mental wellness practitioners and cutting-edge technology. Psychedelic therapy is a holistic and spiritual approach providing healing and has shown successful treatment for many years. Additional information on Mycotopia Therapies can be found on the Company's website at: https://www.mycotopiatherapies.com.
| 
No comments:
Post a Comment